Related Experiment Videos
Nigrostriatal function in humans studied with positron emission tomography.
W R Martin1, M R Palmer, C S Patlak
1Division of Neurology, University of British Columbia, Vancouver, Canada.
Annals of Neurology
|October 1, 1989
Summary
Aging significantly impairs nigrostriatal pathway function, a key dopamine pathway. This study used [18F]6-fluoro-L-dopa and PET scans to confirm age-related decline in asymptomatic individuals.
Area of Science:
- Neuroscience
- Radiochemistry
- Gerontology
Background:
- Parkinson's disease is linked to dopamine depletion in the substantia nigra.
- This depletion may stem from environmental damage and age-related neuronal loss.
- Age-related decline in nigrostriatal pathway function is crucial to this hypothesis.
Purpose of the Study:
- To investigate the in vivo effects of aging on the nigrostriatal pathway.
- To assess the functional integrity of nigrostriatal nerve endings in asymptomatic individuals across a wide age range.
Main Methods:
- Utilized [18F]6-fluoro-L-dopa and positron emission tomography (PET) in 10 asymptomatic subjects (ages 22-80).
- Employed a graphical analysis of tracer-uptake data to model unidirectional transfer.
- Calculated the rate constant (K) as an index of nigrostriatal nerve ending function.
Main Results:
- A significant linear relationship was observed between the rate constant (K) and age (r = 0.80, p < 0.005).
- Nigrostriatal function, indexed by K, decreased by 53.3% across the studied age range.
- Demonstrated the successful application of a unidirectional transfer model for [18F]6-fluoro-L-dopa PET data analysis.
Conclusions:
- Confirmed an age-related impairment of nigrostriatal pathway function in vivo.
- The findings support the hypothesis that age-related neuronal loss contributes to dopamine depletion.
- Highlights the utility of [18F]6-fluoro-L-dopa PET for assessing nigrostriatal integrity across the lifespan.